Streamlining MEDITECH Emgality Prior Authorization Workflows

Klivira automates the complex MEDITECH Emgality prior authorization process, reducing manual effort and accelerating patient access to critical migraine therapy. Our platform integrates seamlessly with MEDITECH environments to optimize your revenue cycle.

Navigating prior authorizations for high-volume specialty drugs like Emgality within a MEDITECH EMR environment presents unique challenges for revenue cycle directors and PA coordinators. The variability across MEDITECH product lines, from modern Expanse to legacy systems, demands a flexible and robust automation solution. Klivira addresses these complexities by integrating directly into your clinical workflows.

Emgality Prior Authorization Flow within MEDITECH

The prior authorization process for Emgality, a CGRP inhibitor for migraine prevention, typically begins with an order within the MEDITECH EMR. Klivira intercepts these orders, triggering an automated PA workflow. This includes identifying the specific payer requirements and whether Emgality falls under pharmacy or medical benefit, a critical distinction for accurate submission.

Leveraging MEDITECH Integration Surfaces for ePA

Klivira integrates with MEDITECH's diverse integration surfaces to gather necessary clinical data for Emgality PAs. For MEDITECH Expanse customers, we utilize FHIR R4 APIs and SMART App Launch capabilities to pull patient demographics, diagnoses, and medication history. For legacy MEDITECH 6.x, C/S, or Magic environments, we also leverage HL7 v2 interfaces, which remain operationally essential for many deployments, ensuring comprehensive data capture regardless of your specific MEDITECH product line.

Automated Documentation Retrieval for Emgality PA

Successful Emgality prior authorizations require robust clinical documentation. Klivira automatically identifies and extracts relevant data from MEDITECH's patient chart, including clinical notes, problem lists, and prior treatment failures. In Expanse, this often involves pulling from the Patient Summary / Storyboard and Documentation modules, compiling a complete evidence packet to support the medical necessity for Emgality.

Specialty Pharmacy Coordination from MEDITECH

Once an Emgality prior authorization is approved, Klivira facilitates the seamless routing of the prescription to the appropriate specialty pharmacy. Our platform helps manage the communication loop between the EMR, payer, and pharmacy, ensuring that the patient can access their medication without unnecessary delays. This reduces manual handoffs and improves overall care coordination.

Navigating Product-Line Variability in MEDITECH ePA

MEDITECH's integration surface and chart anatomy vary significantly across its product lines. Klivira's approach is designed to accommodate this variability, providing consistent prior authorization automation whether you're operating on MEDITECH Expanse, a mixed environment, or an older version. Our integration strategy is tailored to your specific MEDITECH deployment to ensure optimal performance and data exchange.

Frequently asked questions

How does Klivira handle the different MEDITECH product lines for Emgality PA?

Klivira's integration strategy accounts for MEDITECH's product-line variability. For Expanse, we leverage FHIR R4 APIs and SMART App Launch. For legacy systems, we also utilize HL7 v2 interfaces to ensure comprehensive data capture and workflow automation across your entire MEDITECH footprint.

Can Klivira integrate with MEDITECH to pull specific clinical notes for Emgality PA?

Yes, Klivira is designed to pull relevant clinical documentation from MEDITECH. In Expanse, this includes data from the Patient Summary / Storyboard and Documentation modules, enabling us to build a robust prior authorization packet with the necessary evidence for Emgality.

Does Klivira support write-back of PA status into MEDITECH?

Klivira supports write-back of prior authorization status into MEDITECH where EMR write APIs are available and configured. While write-back capabilities via FHIR are more limited than read across MEDITECH product lines, we work with your IT team to establish the most effective methods for updating PA status directly within your MEDITECH environment.

How does Klivira address the medical vs. pharmacy benefit distinction for Emgality?

Klivira's platform is configured to identify whether Emgality falls under the medical or pharmacy benefit based on payer-specific rules and the ordering context. This ensures that the prior authorization request is submitted through the correct channel (e.g., X12 278 for medical, NCPDP SCRIPT for pharmacy) to minimize denials and delays.

What kind of data does Klivira pull from MEDITECH to support Emgality PAs?

Klivira pulls essential data such as patient demographics, diagnoses (e.g., migraine with aura, chronic migraine), medication history (e.g., prior failed treatments), and relevant clinical notes detailing the patient's condition and treatment rationale. This comprehensive data set is crucial for demonstrating medical necessity for Emgality.